» Articles » PMID: 16868314

Mitochondrial Uncoupling: a Key Contributor to Reduced Cardiac Efficiency in Diabetes

Overview
Specialty Physiology
Date 2006 Jul 27
PMID 16868314
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease is the primary cause of death in individuals with obesity and diabetes. However, the underlying mechanisms for cardiac dysfunction are partially understood. Studies have suggested that altered cardiac metabolism may play a role. The diabetic heart is characterized by increased fatty acid oxidation, increased myocardial oxygen consumption, and reduced cardiac efficiency. Here, we review possible mechanisms for reduced cardiac efficiency in obesity and diabetes by focusing on the potential role of mitochondrial uncoupling.

Citing Articles

Transcription factor EB, a promising therapeutic target in cardiovascular disease.

Yan X, Yang L, Fu X, Luo X, Wang C, Xie Q PeerJ. 2024; 12:e18209.

PMID: 39403192 PMC: 11472789. DOI: 10.7717/peerj.18209.


Effect of exercise on improving myocardial mitochondrial function in decreasing diabetic cardiomyopathy.

Zhang F, Lin J, Tian H, Wang J Exp Physiol. 2023; 109(2):190-201.

PMID: 37845840 PMC: 10988701. DOI: 10.1113/EP091309.


The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure.

Werbner B, Tavakoli-Rouzbehani O, Fatahian A, Boudina S J Cardiovasc Aging. 2023; 3(1).

PMID: 36742465 PMC: 9894375. DOI: 10.20517/jca.2022.42.


Diabetic cardiomyopathy: Clinical phenotype and practice.

Zhao X, Liu S, Wang X, Chen Y, Pang P, Yang Q Front Endocrinol (Lausanne). 2022; 13:1032268.

PMID: 36568097 PMC: 9767955. DOI: 10.3389/fendo.2022.1032268.


The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy.

Xia W, Li X, Wu Q, Xu A, Zhang L, Xia Z Front Immunol. 2022; 13:951381.

PMID: 36405687 PMC: 9666770. DOI: 10.3389/fimmu.2022.951381.